| Jin Ping Guo, MD | |
|
1 Eves Dr Ste 109, Marlton, NJ 08053-3125 | |
| (856) 797-8886 | |
| Not Available |
| Full Name | Jin Ping Guo |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 39 Years |
| Location | 1 Eves Dr Ste 109, Marlton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205852464 | NPI | - | NPPES |
| 9118403 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA07463200 (New Jersey) | Secondary |
| 207K00000X | Allergy & Immunology | 25MA07463200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocare Llc | 3678562188 | 288 |
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.
› Verified 9 days ago
| Entity Name | Robert J Maro Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952342743 PECOS PAC ID: 5193627826 Enrollment ID: O20040123000195 |
News Archive
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.
› Verified 9 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.
› Verified 9 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jin Ping Guo, MD 401 Route 73 N Ste 320, Marlton, NJ 08053-3426 Ph: (609) 471-1033 | Jin Ping Guo, MD 1 Eves Dr Ste 109, Marlton, NJ 08053-3125 Ph: (856) 797-8886 |
News Archive
Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.
› Verified 9 days ago
Dr. Eugene Anthony Gatti, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 54 E Main St, Marlton, NJ 08053 Phone: 856-988-0570 Fax: 856-988-0303 | |
Dr. Mahendra P Dadhania, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 801 Route 73 North, Ste B, Marlton, NJ 08053 Phone: 856-596-3100 Fax: 856-596-3133 | |
Dr. Gregory Rocco Toci, DO Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 54 E Main St, Marlton, NJ 08053 Phone: 856-988-0570 Fax: 856-988-0303 | |
Sahana Vishwanath, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 54 E Main St, Marlton, NJ 08053 Phone: 856-988-0570 Fax: 856-988-0303 |